Effect of baseline dyskinesia on safety and efficacy of istradefylline, an A2A receptor antagonist, in Parkinson's disease: 8-study pooled analysis

Authors :: Nobutaka Hattori
Daniel D. Truong
Fabrizio Stocchi
P.M. Salzman
K. Toyama
J. Parno
Stuart Isaacson
Olivier Rascol
Akihisa Mori
R. Ristuccia
Source :: Parkinsonism & Related Disorders. 79:e55-e56
Publication Year :: 2020
Publisher :: Elsevier BV, 2020.

Subjects :: Oncology
medicine.medical_specialty
Parkinson's disease
business.industry
medicine.drug_class
Istradefylline
Receptor antagonist
medicine.disease
chemistry.chemical_compound
Pooled analysis
Neurology
chemistry
Dyskinesia
Internal medicine
medicine
Neurology (clinical)
Geriatrics and Gerontology
medicine.symptom
business

Full Text Access

Tools